https://de.marketscreener.com/kurs/aktie/RELIEF-THERAPEUTICS-HOLDI-5527488/news/Relief-Therapeutics-und-NeuroRx-erweitern-die-klinische-RLF-100-Studie-auf-alle-Patienten-mit-schw-30741017/?utm_source=telegram&utm_medium=social&utm_campaign=share